Brief: Cassava Sciences Inc - FDA Requires Additional Information From Cassava For Clinical Study - SEC Filing
03/12/2025 12:51
Dec 3 (Reuters) - Cassava Sciences Inc SAVA.O: CASSAVA SCIENCES INC - FDA REQUIRES ADDITIONAL INFORMATION FROM CASSAVA FOR CLINICAL STUDY - SEC FILING CASSAVA SCIENCES INC - PREPARES TO INITIATE PROOF-OF-CONCEPT STUDY IN FIRST HALF OF 2026 FOR SIMUFILAM - SEC FILING CASSAVA SCIENCES INC - EXPECTS FORMAL LETTER FROM FDA DETAILING ISSUES ON CLINICAL TRIAL FOR SIMUFILAM - SEC FILING Source text: [ID:n0001437749-25-036710] Further company coverage: SAVA.O ((Reuters.Briefs@thomsonreuters.com;))